EHA Unplugged
By European Hematology Association
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by European Hematology Association
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 174
Description
In these EHA-produced podcasts, experts share with you their hematology knowledge and stories. With "EHA Unplugged" we would like to give you the opportunity to unplug from your computer screen, while still learning, by listening to interviews, clinical cases, monologues, and more.
| Episode | Date |
|---|---|
|
How Experts Treat Mantle Cell Lymphoma (with Prof Mats Jerkeman)
|
Feb 06, 2026 |
|
Life After CAR T-cell Therapy: Jonathan Clark’s Journey with Mantle Cell Lymphoma and the Future of Patient Advocacy
|
Jan 30, 2026 |
|
The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)
|
Jan 23, 2026 |
|
How Does Climate Change Affect Hematology Practice? (with Dr Stephen Hibbs)
|
Jan 16, 2026 |
|
Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke)
|
Jan 13, 2026 |
|
EHA Junior Research Grant: Dr Ana Río-Machín’s Journey in AML Research and Collaborative Science
|
Dec 12, 2025 |
|
Hematologists’ Role in the Management of Gaucher Disease (Prof Argiris Symeonidis and Prof Sam Salek)
|
Dec 08, 2025 |
|
Navigating the Toughest Challenges in Hematology Nursing: Insights from HNHCP Leaders
|
Nov 28, 2025 |
|
A Multiple Myeloma and MRD Pioneer: EHA 2025 Lifetime Achievement Award (Prof Jesús San-Miguel)
|
Nov 21, 2025 |
|
Young Hematologists in the Spotlight: EHA2025 Young EHA Award (Dr Mandy Lauw)
|
Nov 14, 2025 |
|
Supporting Hematology Innovation: Outcomes of an EHA Junior Research Grant (with Dr Ferran Nadeu Prat)
|
Nov 07, 2025 |
|
Ethical Considerations in Gene Therapy for Sickle Cell Disease and Thalassemia (with Prof Mariane de Montalembert)
|
Oct 31, 2025 |
|
Point-of-care Tests for Neonatal Screening of Sickle Cell Disease (with Prof Béatrice Gulbis)
|
Oct 24, 2025 |
|
What the EHA Burnout Survey Reveals for Hematologists (with Dr. Côme Bommier)
|
Oct 17, 2025 |
|
EHA2025 Diversity, Equity, and Inclusion Award: Prof Anna Schuh
|
Oct 10, 2025 |
|
A Successful Mentor’s Mindset: EHA2025 Education & Mentoring Award (Prof Jan Cools)
|
Oct 03, 2025 |
|
EHA Clinical Excellence Award 2025: Prof Khaled Musallam
|
Sep 26, 2025 |
|
Setting the Standard for Quality Care in Hematologic Malignancies (with Prof John Gribben)
|
Sep 17, 2025 |
|
Hematology Portraits: Prof Kirsten Grønbæk
|
Aug 29, 2025 |
|
Hematology Portraits: Prof Maria Domenica Cappellini
|
Aug 22, 2025 |
|
Gene Therapy Advances in SCD and B-Thalassemia (with Dr Stefano Rivella)
|
Aug 15, 2025 |
|
AML Management in the Old and Unfit (with Prof Hartmut Döhner)
|
Aug 08, 2025 |
|
Managing Young Fit AML patients with Prof Konstanze Döhner
|
Jul 31, 2025 |
|
GoCART Coalition (with Prof Christian Chabannon)
|
Jul 25, 2025 |
|
Empowering Healthcare through Patient Advocacy (with Jan Geissler)
|
Jul 18, 2025 |
|
Off-the-shelf CAR T-cells from iPSCs (with Prof Maria Themeli)
|
Jul 12, 2025 |
|
AIDPATH – AI automated CAR T-cell manufacturing (with Dr Carmen Sanges)
|
Jul 04, 2025 |
|
Hematology Portraits: prof. Elizabeth Macintyre
|
Jun 20, 2025 |
|
Is low-risk MDS really low risk? (with Prof Uwe Platzbecker)
|
Jun 06, 2025 |
|
MRD Monitoring in MDS Patients (with Prof Arjan van de Loosdrecht)
|
May 30, 2025 |
|
Hematology Portraits: prof. Martin Dreyling
|
May 23, 2025 |
|
MDS Pathophysiology and the Role of Immune Dysfunction (with Dr Shahram Kordasti)
|
May 16, 2025 |
|
Mapping Rare Anemia Patient Data: RADeep (with Dr. María del Mar Mañú Pereira)
|
May 10, 2025 |
|
Hematology Portraits: prof. Antonio Almeida
|
Apr 25, 2025 |
|
Targeting the Immune System in MDS (featuring Prof Dominik Wolf)
|
Apr 18, 2025 |
|
Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke)
|
Apr 11, 2025 |
|
The Current Diagnostic Approach to MDS (with Dr Onima Chowdhury)
|
Apr 04, 2025 |
|
Hematology Portraits: Prof Brian Huntly
|
Apr 01, 2025 |
|
Mental Health in CLL
|
Mar 21, 2025 |
|
Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia
|
Mar 14, 2025 |
|
Hematology Portraits: Prof Kostas Stamatopoulos
|
Feb 28, 2025 |
|
Management of High-risk MDS: Seeking Clarity for Classification and Treatment
|
Feb 14, 2025 |
|
Hematopoietic Stem Cells in Health, Aging and Malignancy: Focus on Metabolism (EHA2024)
|
Feb 07, 2025 |
|
Innovative Trial Design (EHA2024)
|
Jan 31, 2025 |
|
Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024)
|
Jan 24, 2025 |
|
Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024)
|
Jan 20, 2025 |
|
Iron Metabolism in Myelodysplastic Syndrome (MDS)
|
Jan 10, 2025 |
|
First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024)
|
Dec 27, 2024 |
|
Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024)
|
Dec 21, 2024 |
|
Iron and Infections: Back to the Future (EHA2024)
|
Dec 13, 2024 |
|
Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024)
|
Dec 06, 2024 |
|
Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history?
|
Nov 29, 2024 |
|
The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)
|
Nov 22, 2024 |
|
From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)
|
Nov 18, 2024 |
|
Screening for Sickle Cell Disease (with Prof David Rees)
|
Nov 08, 2024 |
|
The Environmental Impact on Hematology Practice (with Dr Stephen Hibbs)
|
Nov 01, 2024 |
|
Synthetic Patients: The Future of Clinical Trials?
|
Oct 25, 2024 |
|
Innovative tools for Disease Monitoring in Multiple Myeloma
|
Oct 18, 2024 |
|
Hematology Portraits: Prof Ivo Touw
|
Oct 11, 2024 |
|
Preventing Venous Thromboembolism (VTE) in Pregnant Women
|
Oct 04, 2024 |
|
Gene Therapy for Hemophilia
|
Sep 17, 2024 |
|
AI-driven Morphology in Hematology
|
Sep 06, 2024 |
|
Regulatory Landscape for CAR T-cell Therapy
|
Aug 30, 2024 |
|
Point-of-care CAR T-cell Manufacturing
|
Aug 23, 2024 |
|
Processes in CAR T-cell Therapy
|
Aug 16, 2024 |
|
CAR T-cell Therapy for Children with ALL
|
Aug 09, 2024 |
|
CAR T-cell Therapy in AML: State of the Art
|
Aug 02, 2024 |
|
Ethical Considerations in CAR T-cell Therapy
|
Jul 26, 2024 |
|
CAR T-cell Therapy - A Patient's Perspective
|
Jul 19, 2024 |
|
Developments in CAR T-cell Therapy
|
Jul 12, 2024 |
|
Precision Medicine in Myelodysplastic Syndromes (MDS)
|
Jul 05, 2024 |
|
Diversity, Equity, and Inclusion in Hematology
|
Jun 28, 2024 |
|
Trends in CAR T-cell Therapy
|
Jun 21, 2024 |
|
Precision Medicine in Chronic Lymphocytic Leukemia (CLL)
|
May 24, 2024 |
|
Precision Medicine in Rare Hematological Diseases: Pyruvate Kinase Activators
|
May 01, 2024 |
|
Precision Medicine in Follicular Lymphoma
|
Apr 26, 2024 |
|
Precision Medicine in Multiple Myeloma
|
Apr 12, 2024 |
|
Precision Medicine in Myeloproliferative Neoplasms
|
Apr 05, 2024 |
|
Precision Medicine and Clonal Hematopoiesis
|
Mar 29, 2024 |
|
Precision Medicine: Hepcidin Mimetics for Polycythemia Vera Treatment
|
Mar 15, 2024 |
|
Precision Medicine in Inherited Bone Marrow Failure Syndromes
|
Feb 16, 2024 |
|
The Whats in Scientific Publishing
|
Dec 01, 2023 |
|
The New Classification of Hemochromatosis: Why and How
|
Nov 17, 2023 |
|
Diversity, equity, and inclusion: Why this is important?
|
Nov 10, 2023 |
|
Unraveling Autoimmune Neutropenia: From Childhood to Adulthood
|
Nov 03, 2023 |
|
Navigating the World of Hematology Research: from Mentorship to Work-Life Balance
|
Oct 27, 2023 |
|
Myelodysplastic Syndrome (MDS) with Prof Kirsten Grønbæk
|
Oct 20, 2023 |
|
Immune cell therapies and targeted therapies in AML
|
Oct 13, 2023 |
|
Patient Communication and Self Care
|
Oct 09, 2023 |
|
Building prognostic models using big data with Prof Kimmo Porkka
|
Sep 29, 2023 |
|
Myeloma - Prof Jorge Sierra
|
Sep 22, 2023 |
|
Lymphoma - Dr Umut Yilmaz
|
Sep 15, 2023 |
|
How to Get Started in Hematology Research - Dr Anastasia Conti, Assoc Prof Maria Paola Martelli and Dr Simona Valletta
|
Sep 08, 2023 |
|
Pediatric Hematology - Dr Mirjam Belderbos
|
Sep 01, 2023 |
|
Iron metabolism: physiology and pathology
|
Aug 25, 2023 |
|
Pathogenesis and Management of Acute Chest Syndrome (ACS) in SCD
|
Aug 11, 2023 |
|
EHA Unplugged: MDS Classification and Risk Assessment
|
Aug 04, 2023 |
|
New Treatment of Iron Metabolism Defects: A Focus on Anemia of Inflammation
|
Jul 28, 2023 |
|
Latest Innovations and Future Perspectives in CAR-T Therapy
|
Jul 21, 2023 |
|
Current CAR-T Treatment for Lymphomas Focusing on DLBCL
|
Jul 14, 2023 |
|
Clinical Management of CAR-T Therapy in Myeloma
|
Jul 07, 2023 |
|
Challenges in receiving CAR-T treatment: Patient's perspective
|
Jun 30, 2023 |
|
Ph+ acute lymphoblastic lymphoma and the immune system in hematological neoplasms.
|
Jun 23, 2023 |
|
CAR-T Treatment in Myeloma: State of the Art
|
Jun 02, 2023 |
|
Reasons for Failure and Relapse and Mechanisms of Resistance in CAR-T
|
May 26, 2023 |
|
Economic Aspects of CAR-T: Challenges and Solutions
|
May 18, 2023 |
|
Update on CAR-T Therapies in Acute and Chronic Leukemias
|
May 12, 2023 |
|
Spotlight Talks: How I Treat Absolute Iron Deficiency in Inflammatory Disorders
|
Apr 28, 2023 |
|
Overview of the Current CAR-T Landscape
|
Apr 21, 2023 |
|
Papers Unplugged: Precision Medicine and Myeloid Neoplasms
|
Apr 14, 2023 |
|
Debate: Gene Addition or Gene Editing for Hemoglobinopathies?
|
Apr 07, 2023 |
|
What's in Store for Lymphoid Malignancies?
|
Mar 31, 2023 |
|
Spotlight Talks: Postpartum Hemorrhage (PPH)
|
Mar 24, 2023 |
|
Papers Unplugged: The Perspectives of Doctors and Patients in the Treatment of CLL
|
Mar 17, 2023 |
|
Papers Unplugged: Precision Medicine in AML
|
Mar 10, 2023 |
|
Debate: Should Low Risk PV-MF Patients be Treated?
|
Mar 03, 2023 |
|
Health Technology Assessment (HTA)
|
Mar 01, 2023 |
|
Spotlight Talks: New Agents for the Treatment of Thalassemia
|
Feb 17, 2023 |
|
Papers Unplugged: What's New in the Treatment of CLL?
|
Feb 10, 2023 |
|
Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Myelodysplastic Syndromes
|
Feb 03, 2023 |
|
Papers Unplugged: TIF Guidelines for the Management of Patients with Transfusion-Dependent Thalassemia (TDT)
|
Jan 27, 2023 |
|
Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Lymphoid Diseases
|
Jan 20, 2023 |
|
Papers Unplugged: Is CAR-T Economically Sustainable?
|
Jan 13, 2023 |
|
Papers Unplugged: What Ever Happened to Plan S?
|
Dec 09, 2022 |
|
Papers Unplugged: CHIP and Associated Risk in Elderly Patients
|
Nov 25, 2022 |
|
Papers Unplugged: EHA and War in Ukraine
|
Nov 11, 2022 |
|
Papers Unplugged: Precision Medicine and Hemoglobinopathies
|
Oct 28, 2022 |
|
Naive CLL
|
Jun 10, 2022 |
|
Thrombosis - Bleeding in Cancer
|
Jun 03, 2022 |
|
The Microbiome in HCT
|
May 27, 2022 |
|
Diagnosing Erythrocytosis
|
May 20, 2022 |
|
Clinical Trials of the Future (Clinical Trial)
|
May 16, 2022 |
|
Cutaneous T Cell Lymphoma (CTCL) Episode 1: Presentation and Diagnosis
|
May 13, 2022 |
|
Cutaneous T Cell Lymphoma (CTCL) Episode 2: Treatment
|
May 13, 2022 |
|
Circulating Tumor DNA
|
Apr 08, 2022 |
|
Treating CML in Developing Countries
|
Apr 01, 2022 |
|
Less is More - Transfusion
|
Mar 25, 2022 |
|
Chronic Myeloid Leukemia (Naomi)
|
Mar 04, 2022 |
|
All Good Things Must Come to an End: How and When to End a Clinical Trial (Clinical Trial)
|
Feb 22, 2022 |
|
Iron Deficiency: Perioperative
|
Feb 18, 2022 |
|
Documentation and authorization: Safeguarding the Credibility of Clinical Trials (Clinical Trial)
|
Feb 15, 2022 |
|
Ethical Issues Associated with Treating Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)
|
Feb 11, 2022 |
|
Sponsor: A Role to Take Seriously (Clinical Trial)
|
Feb 08, 2022 |
|
Hematological Changes in Older Adults (Aging Patient: Dispelling Myths)
|
Feb 04, 2022 |
|
Patient Support: Relate and Create (Clinical Trial)
|
Feb 01, 2022 |
|
Treatment of Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)
|
Jan 28, 2022 |
|
The Paper Trail (CRO) (Clinical Trial)
|
Jan 25, 2022 |
|
Patient Assessment In Older Adults (Aging Patient: Dispelling Myths)
|
Jan 21, 2022 |
|
Multiple Myeloma in Underserved Populations (Episode 3)
|
Jan 20, 2022 |
|
What matters in a trial design? (Clinical Trial)
|
Jan 18, 2022 |
|
Aging and Clonal Diseases (Aging Patient: Dispelling Myths)
|
Jan 14, 2022 |
|
Iron Deficiency: Women
|
Dec 31, 2021 |
|
Iron Deficiency: Chronic Kidney Disease
|
Dec 24, 2021 |
|
Iron Deficiency: Heart Failure
|
Dec 17, 2021 |
|
HSCT in Multiple Myeloma
|
Dec 10, 2021 |
|
Multiple Myeloma in Underserved Populations (Episode 2)
|
Dec 07, 2021 |
|
Chronic Lymphocytic Leukemia (CLL)
|
Dec 03, 2021 |
|
Chronic Myeloid Leukemia (CML)
|
Nov 26, 2021 |
|
SCD: What Physicians Can Learn From Patients And Carriers (Episode 3)
|
Nov 16, 2021 |
|
Multiple Myeloma in Underserved Populations (Episode 1)
|
Nov 15, 2021 |
|
SCD: What Physicians Can Learn From Patients And Carriers (Episode 2)
|
Nov 10, 2021 |
|
BCR-ABL1-like ALL
|
Nov 09, 2021 |
|
ALL Hope For The Future
|
Nov 05, 2021 |
|
Iron Homeostasis in Host Defense and Inflammation
|
Oct 29, 2021 |
|
SCD: What Physicians Can Learn From Patients And Carriers (Episode 1)
|
Oct 28, 2021 |
|
Impact of Social Stigma on Coping with SCD
|
Oct 22, 2021 |
|
Interventions in Adolescent SCD
|
Oct 15, 2021 |
|
Sickle Cell Disease in Pregnancy
|
Oct 08, 2021 |
|
HSCT in Paroxysmal Nocturnal Hemoglobinuria
|
Oct 01, 2021 |
|
HSCT in Severe Aplastic Anemia
|
Sep 24, 2021 |
|
Engraftment and Chimerism following HSCT
|
Sep 17, 2021 |
|
Infections in HSCT
|
Sep 06, 2021 |
|
Graft-versus-Host Disease in HSCT
|
Sep 03, 2021 |
|
The History of HSCT
|
Sep 01, 2021 |